RecruitingNCT06021080

Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions


Sponsor

Fujian Provincial Hospital

Enrollment

30 participants

Start Date

Oct 9, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

It is unclear whether different modes of continuous renal replacement therapy (CRRT) impact post-filter ionized calcium concentrations during regional citrate anticoagulation (RCA) when using calcium-containing replacement fluid. This prospective, single-center, observational cohort study will screen all patients receiving CRRT for eligibility. General clinical information will be collected before commencing CRRT treatment. Patients will be randomly assigned to either the veno-venous hemofiltration (CVVH) or continuous veno-venous hemodialysis (CVVHD) group and switch to the alternative mode in the subsequent treatment session. Pre-filter and post-filter ionized calcium, systemic total and ionized calcium, and effluent total and ionized calcium will be measured 2 hours after the initiation of CRRT. Electrolyte levels, arterial blood gases, hourly citrate dose, and total citrate dose will be recorded every 6 hours until the end of CRRT. The primary outcome is the difference in ionized calcium concentrations at each site over time between the two modes.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

  • Age ≥ 18 years old;
  • Receiving citrate anticoagulation;
  • Obtain Informed consent from patients or next of kin.

Exclusion Criteria9

  • Pregnant or lactating women;
  • Allergic to citrate anticoagulants;
  • Severe liver dysfunction (total bilirubin levels exceeding two times the normal range);
  • Hypoxemia (PaO2 \< 60 mmHg);
  • Inadequate tissue perfusion (blood pressure \< 90/60 mmHg despite high doses of vasoactive agents);
  • Hyperlactatemia (lactate\> 4 mmol/L);
  • Hypernatremia;
  • Estimated length of hospital stay \< 48h;
  • Participated in other studies.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECVVH

CVVH therapy

PROCEDURECVVHD

CVVHD therapy


Locations(1)

Fujian Provincial Hospital

Fuzhou, Fujian, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06021080


Related Trials